Skip to content

Mammogram Mail- and Phone-based Interventions

Randomized Comparison of Mail- and Phone-based Interventions Promoting Mammogram Screening

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05853848
Enrollment
14386
Registered
2023-05-11
Start date
2023-05-10
Completion date
2024-07-31
Last updated
2024-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Economics, Behavioral, Mammography, Risk Reduction Behavior, Communication

Brief summary

The project aims to evaluate four different versions and modalities of interventions encouraging mammogram screening among all eligible women due or overdue for screening. The evaluation will compare among the following forms of outreach to help determine whether (a) live calls are more effective at increasing mammogram screening than other forms of outreach and (b) each form of outreach is more effective than no outreach: (1) a postcard, (2) a letter, (3) an auto-dialer phone message, and (4) a live call from a care gaps team. The interventions will be rolled out over many months, allowing for comparisons of effectiveness against those who have not yet been contacted.

Interventions

BEHAVIORALPostcard

Postcard with phone number to call for help scheduling a mammogram.

BEHAVIORALLetter

Letter with phone number to call for help scheduling a mammogram.

BEHAVIORALAuto-dialer

Auto-dialer with option to press button for help scheduling a mammogram.

BEHAVIORALLive call

Live call offering help scheduling a mammogram.

Sponsors

Geisinger Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Intervention model description

Each intervention will be rolled out to only a subset of the total population each month, such that all patients will receive one of the interventions over the course of 7 months. Active arms will be compared contemporaneously against a passive control group consisting of active arm participants for whom the intervention has not yet begun, as well as a random subset of participants who are excluded before the future intervention begins.

Eligibility

Sex/Gender
FEMALE
Age
51 Years to 74 Years
Healthy volunteers
Yes

Inclusion criteria

* Female Geisinger Health Plan members between ages 52 and 74 as of December 31, 2023 * Overdue for annual mammogram * Continuously enrolled with the Geisinger Health Plan as of October 1, 2021 * Can be contacted via both phone and mail

Exclusion criteria

* Geisinger Health Plan members on a do-not-contact list * Had a mammogram as of October 1, 2021 * In hospice, using hospice services, or receiving palliative care as of January 1, 2023 * Medicare members 66 years of age or above at time of outreach, who are institutionalized or have both frailty and advanced illness * Had a bilateral mastectomy at any time

Design outcomes

Primary

MeasureTime frameDescription
Mammogram completedIn the 180 days following the patient's intervention send dateRecord of completed mammogram (yes/no), for comparing postcards, letters, and auto-dialer messages with live calls

Other

MeasureTime frameDescription
Mammogram completedIn the 180 days following the patient's intervention send dateRecord of completed mammogram (yes/no), for comparing across postcards, letters, and auto-dialer messages
Breast malignancy risk detectedIn the 210 days following the patient's intervention send dateRecord of high malignancy risk (yes/no), for comparing across different modalities of outreach
Mammogram appointment scheduledIn the 30 days following the patient's intervention send dateAppointment scheduled for mammogram, among patients visiting Geisinger clinics (yes/no)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026